These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 10887630)

  • 1. On newer treatments for lymphoma.
    Oncology (Williston Park); 2000 Jun; 14(6):794-6. PubMed ID: 10887630
    [No Abstract]   [Full Text] [Related]  

  • 2. Antibody treatment in lymphoma.
    Leonard JP
    Clin Adv Hematol Oncol; 2009 Feb; 7(2):106-7. PubMed ID: 19367250
    [No Abstract]   [Full Text] [Related]  

  • 3. [Antibody therapy in hematology and oncology - part 1].
    Kneba M; Schrader C; Köhne H
    Med Klin (Munich); 2008 Dec; 103(12):843-59. PubMed ID: 19099214
    [No Abstract]   [Full Text] [Related]  

  • 4. Rituximab.
    Multani P; White CA
    Cancer Chemother Biol Response Modif; 2003; 21():235-58. PubMed ID: 15338748
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment of HBV-carrying lymphoma patients with Rituximab and CHOP: a diagnostic and therapeutic challenge.
    Skrabs C; Müller C; Agis H; Mannhalter C; Jäger U
    Leukemia; 2002 Sep; 16(9):1884-6. PubMed ID: 12200717
    [No Abstract]   [Full Text] [Related]  

  • 6. Recurrent pericardial effusion after treatment for primary effusion lymphoma-like lymphoma: an autopsied case.
    Kagoya Y; Takahashi T; Yoshimoto T; Ichikawa M; Hangaishi A; Fukayama M; Kurokawa M
    Ann Hematol; 2011 Feb; 90(2):219-20. PubMed ID: 20432036
    [No Abstract]   [Full Text] [Related]  

  • 7. [Immunotherapy with monoclonal antibody of malignant lymphoma].
    Ogura M
    Nihon Rinsho; 2007 Jan; 65 Suppl 1():545-60. PubMed ID: 17474462
    [No Abstract]   [Full Text] [Related]  

  • 8. What Is the best treatment for HIV-associated multicentric Castleman disease?
    Bower M; Dalla Pria A
    Clin Adv Hematol Oncol; 2012 Mar; 10(3):207-9. PubMed ID: 22402432
    [No Abstract]   [Full Text] [Related]  

  • 9. [Aggressive lymphomas].
    Haioun C; Reyes F
    Rev Prat; 2002 May; 52(9):972-7. PubMed ID: 12063763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant polyclonal antibodies: the next generation of antibody therapeutics?
    Haurum JS
    Drug Discov Today; 2006 Jul; 11(13-14):655-60. PubMed ID: 16793535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Monoclonal antibodies in the treatment of lymphoma].
    Mounier N; Gisselbrecht C
    Rev Prat; 2002 May; 52(9):982-5. PubMed ID: 12063765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-Lymphoma Monoclonal Antibodies: Making Better Antibodies and Making Antibodies Better.
    Weiner GJ
    Trans Am Clin Climatol Assoc; 2015; 126():87-92. PubMed ID: 26330662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. About the old and the new: gallium-67 scintigraphy to rituximab for lymphoma.
    DeNardo GL
    Cancer Biother Radiopharm; 1999 Aug; 14(4):235-6. PubMed ID: 10850308
    [No Abstract]   [Full Text] [Related]  

  • 14. The challenge of recurrent follicular lymphoma.
    Tomás JF
    Lancet Oncol; 2011 Aug; 12(8):714-6. PubMed ID: 21724461
    [No Abstract]   [Full Text] [Related]  

  • 15. Rituximab not affected by statins?
    Pharmacogenomics; 2009 Feb; 10(2):259. PubMed ID: 19207027
    [No Abstract]   [Full Text] [Related]  

  • 16. Claimed association of absolute lymphocyte count with therapeutic efficacy of radio-immunotherapy in patients with indolent lymphoma cannot be verified in an independent data set.
    Bishton MJ; Hicks RJ; Prince HM; Ritchie DS; Wolf M; Seymour JF
    Leukemia; 2008 Dec; 22(12):2259-60; author reply 2260-1. PubMed ID: 18480835
    [No Abstract]   [Full Text] [Related]  

  • 17. [New data prove therapeutic superiority. MabThera in follicular and mantle cell lymphoma].
    Krankenpfl J; 2002; 40(5-6):161. PubMed ID: 12271501
    [No Abstract]   [Full Text] [Related]  

  • 18. Newer treatments for non-Hodgkin's lymphoma: monoclonal antibodies.
    Maloney DG; Press OW
    Oncology (Williston Park); 1998 Oct; 12(10 Suppl 8):63-76. PubMed ID: 9830635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regression of cutaneous intravascular lymphoma with rituximab.
    Han K; Haley JC; Carlson K; Pinter-Brown L; Soriano T
    Cutis; 2003 Aug; 72(2):137-40. PubMed ID: 12953938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Developing new monoclonal antibodies for aggressive lymphoma: a challenging road in the rituximab era.
    Friedberg JW
    Clin Cancer Res; 2004 Aug; 10(16):5297-8. PubMed ID: 15328164
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.